Integrated Micro-Chromatography Systems

Executive Summary

Integrated Micro-Chromatography Systems (IMCS) is a U.S.-based company specializing in enzymatic and sample preparation technologies for diagnostics and proteomics. Since its founding in 2010 in San Jose, California, IMCS has developed two core product lines: IMCSzyme®, a collection of genetically modified beta-glucuronidase enzymes that rapidly and efficiently hydrolyze multiple drug classes, processing over one million samples monthly; and IMCStips®, a patented automated dispersive solid-phase extraction technology used for high-throughput sample cleanup. These products address critical needs in clinical toxicology, drug monitoring, and proteomic sample preparation, offering speed, purity, and reproducibility.

Upcoming Catalysts (preview)

• Q4 2025FDA clearance for expanded drug panel with IMCSzyme70% success
• Q2 2026Launch of next-generation IMCStips for high-throughput proteomics80% success
• Q3 2026Strategic partnership with a major diagnostics OEM50% success